Kalaris Therapeutics's total assets for Q1 2025 were $103.09M, an increase of 2993.07% from the previous quarter. KLRS total liabilities were $39.22M for the fiscal quarter, a -18.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.